Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials

DESIGN AND INTERVENTION This retrospective study identified patients with refractory GCTs between 1996 and 2004. Patients who had previously received paclitaxel or gemcitabine were excluded from the analysis. Eligible patients received a maximum of six courses of paclitaxel (100 mg/m2 intravenously over 1 h) followed by gemcitabine (1,000 mg/m2… CONTINUE READING